Real-world Survival with CRT plus durvalumab for Unresectable, Stage III NSCLC in Canada: the RELEVANCE Study

P. Wheatley-Price, V. Navani, A. Pabani, B. Routy, S. Snow, M. -H. Denault,Y. Kim, I. Syed, N. Devost, D. Hui, P. Arora, R. Velummailum, A. Springford, C. McKibbon,C. Ho

JOURNAL OF THORACIC ONCOLOGY（2023）

引用 0|浏览0